Intermediate Dose of IV MTX as CNS Prophylaxis for High Risk DLBCL

Clinical trial NCT05054426 · UNKNOWN

Trial details

NCT number: NCT05054426
Sponsor: Peking Union Medical College Hospital
Status: UNKNOWN
Phase: Phase 3
Study type: INTERVENTIONAL

Diffuse Large B Cell Lymphoma Central Nervous System Lymphoma

Start date: 2021-10-08
Primary completion: 2025-10-08
Enrollment: 488

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.